CRVS · Corvus Pharmaceuticals, Inc.
$14.89
-0.25 (-1.65%)
At close · Aug 14
Market Cap
$1.25B
Shares
84.12M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding CRVS
171 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 2,339,506 | $34,226,973 | 0.00% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 2,116,858 | $30,969,633 | 0.42% | Long | 2026-03-31 | |
| iShares Russell 2000 ETF | — | 1,567,922 | $22,938,699 | 0.03% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 820,462 | $12,003,359 | 0.01% | Long | 2026-03-31 | |
| Hood River Small-Cap Growth Fund | — | 744,094 | $10,886,095 | 0.21% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 725,099 | $10,608,198 | 0.10% | Long | 2026-03-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 722,282 | $10,566,986 | 0.08% | Long | 2026-03-31 | |
| Fidelity Small Cap Index Fund | — | 637,084 | $9,677,306 | 0.03% | Long | 2026-04-30 | |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | — | 567,600 | $8,303,988 | 0.10% | Long | 2026-03-31 | |
| Eventide Healthcare & Life Sciences Fund | — | 550,000 | $8,046,500 | 0.51% | Long | 2026-03-31 | |
| iShares Russell 2000 Growth ETF | — | 525,679 | $7,690,684 | 0.06% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 473,326 | $6,924,759 | 0.09% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 380,913 | $4,727,130 | 0.01% | Long | 2026-05-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 330,863 | $4,106,010 | 0.02% | Long | 2026-05-31 | |
| Emerald Growth Fund | — | 188,583 | $2,864,576 | 0.20% | Long | 2026-04-30 | |
| SmallCap Growth Fund I | — | 174,676 | $2,653,328 | 0.11% | Long | 2026-04-30 | |
| iShares Micro-Cap ETF | — | 162,216 | $2,373,220 | 0.20% | Long | 2026-03-31 | |
| THE HARTFORD SMALL COMPANY FUND | — | 147,435 | $2,239,538 | 0.34% | Long | 2026-04-30 | |
| Schwab Small-Cap Index Fund | — | 141,399 | $2,147,851 | 0.03% | Long | 2026-04-30 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 167,995 | $2,084,818 | 0.01% | Long | 2026-05-31 | |
| F/m Emerald Life Sciences Innovation ETF | — | 165,305 | $2,051,435 | 1.95% | Long | 2026-05-31 | |
| VANGUARD U.S. MOMENTUM FACTOR ETF | — | 156,977 | $1,948,085 | 0.11% | Long | 2026-05-31 | |
| Direxion Daily S&P Biotech Bull 3X Shares | — | 121,201 | $1,841,043 | 0.35% | Long | 2026-04-30 | |
| VictoryShares US Small Mid Cap Value Momentum ETF | — | 121,155 | $1,772,498 | 0.13% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 135,399 | $1,680,302 | 0.00% | Long | 2026-05-31 | |
| iShares Genomics Immunology and Healthcare ETF | — | 102,168 | $1,551,932 | 0.97% | Long | 2026-04-30 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 105,776 | $1,547,503 | 0.00% | Long | 2026-03-31 | |
| HARTFORD SMALL COMPANY HLS FUND | — | 95,250 | $1,393,508 | 0.36% | Long | 2026-03-31 | |
| Fidelity Series Total Market Index Fund | — | 112,183 | $1,392,191 | 0.00% | Long | 2026-05-31 | |
| Master Small Cap Index Series | — | 95,146 | $1,391,986 | 0.03% | Long | 2026-03-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 110,424 | $1,370,362 | 0.02% | Long | 2026-05-29 | |
| Tema Oncology ETF | — | 108,477 | $1,346,200 | 0.76% | Long | 2026-05-31 | |
| Nuveen Small Cap Blend Index Fund | — | 77,000 | $1,169,630 | 0.03% | Long | 2026-04-30 | |
| BlackRock Advantage Small Cap Core Fund | — | 90,226 | $1,119,705 | 0.02% | Long | 2026-05-29 | |
| ALPS Medical Breakthroughs ETF | — | 86,347 | $1,071,566 | 0.66% | Long | 2026-05-31 | |
| T.Rowe Price Small Cap Growth Portfolio | — | 68,100 | $996,303 | 0.09% | Long | 2026-03-31 | |
| EQ/2000 Managed Volatility Portfolio | — | 66,905 | $978,820 | 0.03% | Long | 2026-03-31 | |
| Nuveen Equity Index Fund | — | 62,933 | $955,952 | 0.00% | Long | 2026-04-30 | |
| Hood River New Opportunities Fund | — | 62,321 | $911,756 | 0.14% | Long | 2026-03-31 | |
| Small Cap Stock Trust | — | 61,215 | $895,575 | 0.36% | Long | 2026-03-31 | |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund | — | 53,757 | $786,465 | 0.05% | Long | 2026-03-31 | |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND | — | 60,099 | $745,829 | 0.04% | Long | 2026-05-31 | |
| LVIP State Street Small-Cap Index Fund | — | 48,300 | $721,602 | 0.03% | Long | 2026-06-30 | |
| Fidelity Small Cap Growth Index Fund | — | 48,925 | $715,773 | 0.06% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 48,764 | $713,417 | 0.11% | Long | 2026-03-31 | |
| Schwab Total Stock Market Index Fund | — | 46,695 | $709,297 | 0.00% | Long | 2026-04-30 | |
| JPMorgan U.S. Small Company Fund | — | 42,768 | $625,696 | 0.07% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 49,461 | $613,811 | 0.00% | Long | 2026-05-31 | |
| Transamerica T. Rowe Price Small Cap VP | — | 40,700 | $595,441 | 0.09% | Long | 2026-03-31 | |
| MassMutual Small Cap Growth Equity Fund | — | 39,530 | $578,324 | 0.10% | Long | 2026-03-31 |
Showing 1–50 of 171 positions
Key facts
CIK
1626971
CUSIP
221015100
13F (30d)
171 filings
167 filers
Visit website
Investor relations